Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2022 - 2030
Point Of Care Diagnostics Market Growth & Trends
The global point of care diagnostics market size is expected to reach USD 68.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2022 to 2030. The introduction of advanced technologies such as Telehealth enabled POCT is expected to fuel market growth. Furthermore, the rise in the geriatric population and their need for accessible home-based care are anticipated to drive the market.
The adoption of POCT in emerging economies such as Africa and Latin America is anticipated to be a growth determinant of the global POCT market. The authorities are decentralizing the healthcare system and increasing their investments. For instance, the African regulations in Kenya allotted USD 346.7 to Managed Equipment Services project for the government's initiative toward modernizing facilities by procuring new equipment. The Ministry of Health selected GE Health and Philips to offer equipment across 47 countries. Similarly, Latin America decentralized IVD testing, which encourages private players to take strategic initiatives to meet the region’s existing demand for affordable POCT, especially in the infectious diseases segment.
Currently developed POC devices and tests are employed across different medical diagnostic applications, including cancer, pregnancy, and infectious diseases. Patients and physicians employ POC tests to screen conditions, confirm diagnoses, and design suitable therapeutic approaches based on patient health. However, the enthusiasm displayed by different consumers, such as doctors, patients, and caregivers, varies widely. This dynamic consumption pattern of POC diagnostic products is also attributed to economic scalability, financial interests, and lack of a universal healthcare structure.
In the light of COVID-19, the lockdown imposed across the globe has necessitated virtual visits and rapid diagnostic tests that assist patients to avoid hospital visits. Post-lockdown, the eHealth strategy is the emerging area of priority and investment such as an automated patient appointment system, lab result transmission system, healthcare workers' communication system, and medical products procurement system for the companies and governments. It is anticipated to continue to prioritize home-based healthcare delivery even after the pandemic, especially for patients with pre-existing conditions. For instance, NeuroMetrix, Inc. appointed a team to develop the business of DPNCheck, a POCT for peripheral neuropathies. The team is responsible for expanding the footprint in the healthcare market and focusing on the Medicare Advantage population.
Point Of Care Diagnostics Market Report Highlights
The global point of care diagnostics market size is expected to reach USD 68.59 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2022 to 2030. The introduction of advanced technologies such as Telehealth enabled POCT is expected to fuel market growth. Furthermore, the rise in the geriatric population and their need for accessible home-based care are anticipated to drive the market.
The adoption of POCT in emerging economies such as Africa and Latin America is anticipated to be a growth determinant of the global POCT market. The authorities are decentralizing the healthcare system and increasing their investments. For instance, the African regulations in Kenya allotted USD 346.7 to Managed Equipment Services project for the government's initiative toward modernizing facilities by procuring new equipment. The Ministry of Health selected GE Health and Philips to offer equipment across 47 countries. Similarly, Latin America decentralized IVD testing, which encourages private players to take strategic initiatives to meet the region’s existing demand for affordable POCT, especially in the infectious diseases segment.
Currently developed POC devices and tests are employed across different medical diagnostic applications, including cancer, pregnancy, and infectious diseases. Patients and physicians employ POC tests to screen conditions, confirm diagnoses, and design suitable therapeutic approaches based on patient health. However, the enthusiasm displayed by different consumers, such as doctors, patients, and caregivers, varies widely. This dynamic consumption pattern of POC diagnostic products is also attributed to economic scalability, financial interests, and lack of a universal healthcare structure.
In the light of COVID-19, the lockdown imposed across the globe has necessitated virtual visits and rapid diagnostic tests that assist patients to avoid hospital visits. Post-lockdown, the eHealth strategy is the emerging area of priority and investment such as an automated patient appointment system, lab result transmission system, healthcare workers' communication system, and medical products procurement system for the companies and governments. It is anticipated to continue to prioritize home-based healthcare delivery even after the pandemic, especially for patients with pre-existing conditions. For instance, NeuroMetrix, Inc. appointed a team to develop the business of DPNCheck, a POCT for peripheral neuropathies. The team is responsible for expanding the footprint in the healthcare market and focusing on the Medicare Advantage population.
Point Of Care Diagnostics Market Report Highlights
- The glucose testing product segment held the second-largest revenue share in 2021. The high prevalence of diabetes, coupled with the requirement of constant monitoring of blood sugar levels, is contributing to the segment growth
- The home end-use segment is expected to grow lucratively over the forecast period attributed to significant traction of at-home or self-testing for COVID-19. POCT devices are easy to use and do not, mandatorily, require any modern lab infrastructure for testing simpler target analytes in a patient's sample
- North America dominated the global market in 2021 owing to the increasing demand for new technologies, a large pool of key players, and advanced healthcare infrastructure
- Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of cancer, diabetes, cardiovascular diseases, and infectious diseases. The increasing population with limited disposable income is the potential target market for the key players in the region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Market Categorization
1.4.2 Point-Of-Care Testing
1.4.2.1 Poc-End-Use Penetration Mapping
1.4.3 Pricing Analysis
1.4.4 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom Up Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 List Of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Trends And Outlook
3.2 Market Segmentation And Scope
3.3 Parent Market Outlook
3.3.1 Related/Ancillary Market Outlook
3.3.1.1 Molecular Technology Intervention
3.3.1.1.1 Key Factors Considered For Analyzing Molecular Technology Interventions Across Poc Testing
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Introduction Of Clia Waived Tests
3.4.1.2 Rise In Funding From Government And Private Institutions
3.4.1.3 Growing Geriatric Population Base
3.4.1.4 Growing Prevalence Of Target Diseases
3.4.1.5 Growing Demand For Home Healthcare And The Introduction Of Advance Technology Enabled Products
3.4.2 Market Restraint Analysis
3.4.2.1 High Procedure Costs Coupled With Limited Adoption Of Poc Devices In Certain Emerging Regions
3.4.2.2 Presence Of Ambiguous Regulatory As Well As Reimbursement Framework For Primary Care Setting
3.4.3 Market Challenge Analysis
3.4.3.1 Poc Devices Pose Challenges In Maintaining The Quality Standards
3.4.4 Market Opportunity Analysis
3.4.4.1 Networking & Remote Access Integration Of Poc Diagnostics Products
3.4.4.1.1 Smartphone Orientation
3.4.4.1.2 Embedded Vision-Based Solutions
3.4.4.1.3 Digital Technologies
3.5 Penetration And Growth Prospect Mapping For Point Of Care Products, 2021
3.6 Swot By Pest Analysis
3.6.1 Political Landscape
3.6.2 Economic Landscape
3.6.3 Social Landscape
3.6.4 Technology Landscape
3.7 Industry Analysis – Porter’s
3.7.1 Bargaining Power Of Suppliers: Moderate
3.7.2 Bargaining Power Of Buyers: Moderate
3.7.3 Threat Of Substitution: Low
3.7.4 Threat Of New Entrants: Low
3.7.5 Competitive Rivalry: High
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Joint Ventures
3.8.2 Mergers & Acquisitions
3.8.3 Licensing & Partnership
3.9 Market Entry Strategies
3.10 Price-Cost-Margin Analysis For Point-Of-Care Testing
3.11 User Perspective Analysis
3.11.1 Consumer Behavior Analysis
3.12 Technology Overview
3.13 Poc Diagnostics: Market Influencers
3.13.1 High Sensitivity
3.13.2 Shift To Molecular Diagnostics
3.14 Product Positioning Analysis, 2021
3.14.1 Glucose Testing
3.14.2 Hb1ac Testing
3.14.3 Coagulation Testing
3.14.4 Fertility/Pregnancy
3.14.5 Infectious Disease
3.14.6 Cardiac Markers
3.14.7 Thyroid Stimulating Hormone
3.14.8 Haematology
3.14.9 Primary Care Systems
3.14.10 Decentralized Clinical Chemistry
3.14.11 Feces
3.14.12 Lipid Testing
3.14.13 Cancer Marker
3.14.14 Blood Gas/Electrolytes
3.14.15 Ambulatory Chemistry
3.14.16 Drug Of Abuse (Doa) Testing
3.14.17 Urinalysis/Nephrology
3.15 Regulatory Framework Analysis For U.S. Point Of Care Diagnostics
3.16 Regulatory Framework Analysis For Europe Point Of Care Diagnostics
3.17 Regulatory Framework Analysis For Japan Point Of Care Diagnostics
CHAPTER 4 COVID-19 IMPACT ANALYSIS
4.1 Overview
4.1.1 Covid-19 Point-Of-Care Diagnostics: Technology Overview
4.1.2 Covid-19 Point-Of-Care Diagnostics: Regulatory Overview
CHAPTER 5 COMPETITIVE ANALYSIS.
5.1 Recent Developments & Impact Analysis, By Key Market Participants
5.2 Company/Competition Categorization
5.3 Vendor Landscape
5.3.1 Key Distributors Marketing Channels
5.3.1.1 Abbott Diagnostics
5.3.1.1.1 Abbott Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.1.2 Alere Inc.
5.3.1.1.2.1 Alere: Marketing Channels & Distribution Network For Poc
5.3.1.2 Roche Diagnostics
5.3.1.2.1 Roche Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.3 Siemens Healthcare
5.3.1.3.1 Siemens Healthcare: Marketing Channels & Distribution Network For Poc
5.3.1.4 Danaher Corporation
5.3.1.4.1 Danaher Corporation: Marketing Channels & Distribution Network For Poc
5.3.1.5 Instrumentation Laboratory Spa.
5.3.1.5.1 Instrumentation Laboratory Spa.: Marketing Channels & Distribution Network For Poc
5.3.1.6 Becton Dickinson
5.3.1.6.1 Becton Dickinson.: Marketing Channels & Distribution Network For Poc
5.3.2 Key Customers
5.4 Key Company Market Ranking, 2021
5.4.1 Company Size
5.4.2 Distribution Network
5.4.3 Product Portfolio
5.4.4 Segment Coverage
5.4.5 Geographic Presence
5.4.6 Collaborations
5.4.7 Conclusion
5.5 Public Companies
5.5.1 Number Of Products
5.5.2 Market Penetration
5.5.3 Strategic Initiatives
5.5.4 Segment Coverage
5.5.5 Geographical Presence
5.5.6 Competitive Dashboard Analysis
5.6 Market Differentiators
5.6.1 Application Trends
5.6.2 Technology Trends
5.6.3 Test Location Trends
5.6.4 End-Use Trends
5.6.5 Regional Trends
5.7 Private Companies
5.7.1 New Entrants/Emerging Players
5.8 Regional Mapping: Public And Private Companies
CHAPTER 6 PRODUCT BUSINESS ANALYSIS
6.1 Point-Of-Care (Poc) Diagnostics Market: Product Movement Analysis
6.1.1 Glucose Testing
6.1.1.1 Glucose Testingpoint-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.2 Hb1ac Testing
6.1.2.1 Hb1ac Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.3 Coagulation Testing
6.1.3.1 Coagulation Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.4 Fertility/Pregnancy
6.1.4.1 Fertility/Pregnancy Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5 Infectious Diseases
6.1.5.1 Infectious Disease Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.2 Hiv Poc
6.1.5.2.1 Hiv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.3 Clostridium Difficile Poc
6.1.5.3.1 Clostridium Difficile Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.4 Hbv Poc
6.1.5.4.1 Hbv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.5 Pneumonia Or Streptococcus Associated Infections
6.1.5.5.1 Pneumonia Or Streptococcus Associated Infections Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.6 Respiratory Syncytial Virus (Rsv) Poc
6.1.5.6.1 Respiratory Syncytial Virus (Rsv) Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.7 Hpv Poc
6.1.5.7.1 Hpv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.8 Influenza/Flu Poc
6.1.5.8.1 Influenza/Flu Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.9 Hcv Poc
6.1.5.9.1 Hcv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.10 Mrsa Poc
6.1.5.10.1 Mrsa Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.11 Tb And Drug-Resistant Tb Poc
6.1.5.11.1 Tb And Drug-Resistant Tb Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.12 Hsv Poc
6.1.5.12.1 Hsv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.13 Covid-19
6.1.5.13.1 Covid-19 Diagnostics Market Estimates And Forecast, 2020 – 2030 (Usd Million)
6.1.5.14 Other Infectious Diseases
6.1.5.14.1 Other Infectious Disease Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.6 Cardiac Markers
6.1.6.1 Cardiac Markers Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.7 Thyroid Stimulating Hormone
6.1.7.1 Thyroid Stimulating Hormone Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.8 Hematology
6.1.8.1 Hematology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.9 Primary Care Systems
6.1.9.1 Primary Care Systems Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.10 Decentralized Clinical Chemistry
6.1.10.1 Decentralized Clinical Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.11 Feces
6.1.11.1 Feces Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.12 Lipid Testing
6.1.12.1 Lipid Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.13 Cancer Marker
6.1.13.1 Cancer Marker Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.14 Blood Gas/Electrolytes
6.1.14.1 Blood Gas/Electrolytes Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.15 Ambulatory Chemistry
6.1.15.1 Ambulatory Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.16 Drug Of Abuse (Doa) Testing
6.1.16.1 Drug Of Abuse (Doa) Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.17 Urinalysis/Nephrology
6.1.17.1 Urinalysis/Nephrology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
CHAPTER 7 END-USE BUSINESS ANALYSIS
7.1 Point-Of-Care (Poc) Diagnostics Market: End-Use Movement Analysis
7.1.1 Clinics
7.1.1.1 Point-Of-Care (Poc) Diagnostics Market For Clinics, 2018 - 2030 (Usd Million)
7.1.1.2 Pharmacy & Retail Clinics
7.1.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Pharmacy & Retail Clinics, 2018 - 2030 (Usd Million)
7.1.1.3 Physician Office
7.1.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Physician Office, 2018 - 2030 (Usd Million)
7.1.1.4 Urgent Care Clinics
7.1.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Urgent Care Clinics, 2018 - 2030 (Usd Million)
7.1.1.5 Non-Practice Clinics
7.1.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Non-Practice Clinics, 2018 - 2030 (Usd Million)
7.1.2 Hospitals
7.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Hospitals, 2018 - 2030 (Usd Million)
7.1.3 Home
7.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Home, 2018 - 2030 (Usd Million)
7.1.4 Assisted Living Healthcare Facilities
7.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Assisted Living Healthcare Facilities, 2018 - 2030 (Usd Million)
7.1.5 Laboratory
7.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Laboratory, 2018 - 2030 (Usd Million)
CHAPTER 8 REGION BUSINESS ANALYSIS
8.1 Point-Of-Care (Poc) Diagnostics Market: Regional Movement Analysis, 2021 & 2030
8.2 North America
8.2.1.1 North America Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.2.2 U.S.
8.2.3 Canada
8.3 Europe
8.3.1.1 Europe Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Italy
8.3.6 Spain
8.3.7 Russia
8.4 Asia Pacific
8.4.1.1 Asia Pacific Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.4.2 Japan
8.4.3 China
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.5 Latin America
8.5.1.1 Latin America Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.5.2 Brazil
8.5.3 Mexico
8.6 Middle East & Africa (Mea)
8.6.1.1 Middle East & Africa Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.6.2 South Africa
8.6.3 Saudi Arabia
CHAPTER 9 COMPANY PROFILE
9.1 Company Profiles
9.1.1 Wipro Limited
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 Zoe Global Limited
9.1.2.1 Company Overview
9.1.2.2 Product Benchmarking
9.1.3 Vocalis Health
9.1.3.1 Company Overview
9.1.3.2 Product Benchmarking
9.1.3.3 Strategic Initiatives
9.1.4 Darwinai
9.1.4.1 Company Overview
9.1.4.2 Product Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Biocogniv, Inc.
9.1.5.1 Company Overview
9.1.5.2 Product Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 Laipac Technology, Inc.
9.1.6.1 Company Overview
9.1.6.2 Product Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Gauss Surgical
9.1.7.1 Company Overview
9.1.7.2 Product Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Oxford Immune Algorithmics Ltd.
9.1.8.1 Company Overview
9.1.8.2 Product Benchmarking
9.1.8.3 Strategic Initiatives
9.1.9 F. Hoffmann-La Roche Ltd.
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Qiagen
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11 Danaher Corporation
9.1.11.1 Company Overview
9.1.11.2 Beckman Coulter, Inc.
9.1.11.2.1 Company Overview
9.1.11.2.2 Radiometer Medical Aps
9.1.11.2.3 Hemocue Ab
9.1.11.3 Financial Performance
9.1.11.4 Product Benchmarking
9.1.11.5 Strategic Initiatives
9.1.12 Becton Dickinson (Bd)
9.1.12.1 Company Overview
9.1.12.2 Financial Performance
9.1.12.3 Product Benchmarking
9.1.12.4 Strategic Initiatives
9.1.13 Biomerieux Sa
9.1.13.1 Company Overview
9.1.13.2 Financial Performance
9.1.13.3 Product Benchmarking
9.1.13.4 Strategic Initiatives
9.1.14 Abbott
9.1.14.1 Company Overview
9.1.14.2 Alere, Inc.
9.1.14.2.1 Company Overview
9.1.14.3 Financial Performance
9.1.14.4 Product Benchmarking
9.1.14.5 Strategic Initiatives
9.1.14.5.1 Strategic Initiatives (Alere)
9.1.15 Siemens Healthcare Ag
9.1.15.1 Company Overview
9.1.15.2 Financial Performance
9.1.15.3 Product Benchmarking
9.1.15.4 Strategic Initiatives
9.1.16 Zoetis, Inc.
9.1.16.1 Company Overview
9.1.16.2 Abaxis
9.1.16.3 Company Overview
9.1.16.4 Financial Performance
9.1.16.4.1 Financial Performance (Abaxis)
9.1.16.5 Product Benchmarking
9.1.16.6 Strategic Initiatives
9.1.17 Instrumentation Laboratory
9.1.17.1 Company Overview
9.1.17.2 Accriva Diagnostics
9.1.17.2.1 Company Overview
9.1.17.3 International Technidyne Corporation (Itc)
9.1.17.3.1 Company Overview
9.1.17.4 Financial Performance (Instrumentation Laboratory)
9.1.17.4.1 Financial Performance (International Technidyne)
9.1.17.5 Product Benchmarking
9.1.17.6 Strategic Initiatives
9.1.18 Nova Biomedical
9.1.18.1 Company Overview
9.1.18.2 Financial Performance
9.1.18.3 Product Benchmarking
9.1.18.4 Strategic Initiatives
9.1.19 Trividia Health, Inc.
9.1.19.1 Company Overview
9.1.19.2 Financial Performance
9.1.19.3 Product Benchmarking
9.1.19.4 Strategic Initiatives
9.1.20 Quidel Corporation
9.1.20.1 Company Overview
9.1.20.2 Financial Performance
9.1.20.3 Product Benchmarking
9.1.20.4 Strategic Initiatives
9.1.21 Trinity Biotech
9.1.21.1 Company Overview
9.1.21.2 Financial Performance
9.1.21.3 Product Benchmarking
9.1.21.4 Strategic Initiatives
9.1.22 Sekisui Diagnostics
9.1.22.1 Company Overview
9.1.22.2 Product Benchmarking
9.1.22.3 Strategic Initiatives
9.1.23 Orasure Technologies, Inc.
9.1.23.1 Company Overview
9.1.23.2 Financial Performance
9.1.23.3 Product Benchmarking
9.1.23.4 Strategic Initiatives
9.1.24 Nipro
9.1.24.1 Company Overview
9.1.24.2 Financial Performance
9.1.24.3 Product Benchmarking
9.1.25 Spectral Medical Inc.
9.1.25.1 Company Overview
9.1.25.2 Financial Performance
9.1.25.3 Product Benchmarking
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Market Categorization
1.4.2 Point-Of-Care Testing
1.4.2.1 Poc-End-Use Penetration Mapping
1.4.3 Pricing Analysis
1.4.4 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom Up Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 List Of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Trends And Outlook
3.2 Market Segmentation And Scope
3.3 Parent Market Outlook
3.3.1 Related/Ancillary Market Outlook
3.3.1.1 Molecular Technology Intervention
3.3.1.1.1 Key Factors Considered For Analyzing Molecular Technology Interventions Across Poc Testing
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Introduction Of Clia Waived Tests
3.4.1.2 Rise In Funding From Government And Private Institutions
3.4.1.3 Growing Geriatric Population Base
3.4.1.4 Growing Prevalence Of Target Diseases
3.4.1.5 Growing Demand For Home Healthcare And The Introduction Of Advance Technology Enabled Products
3.4.2 Market Restraint Analysis
3.4.2.1 High Procedure Costs Coupled With Limited Adoption Of Poc Devices In Certain Emerging Regions
3.4.2.2 Presence Of Ambiguous Regulatory As Well As Reimbursement Framework For Primary Care Setting
3.4.3 Market Challenge Analysis
3.4.3.1 Poc Devices Pose Challenges In Maintaining The Quality Standards
3.4.4 Market Opportunity Analysis
3.4.4.1 Networking & Remote Access Integration Of Poc Diagnostics Products
3.4.4.1.1 Smartphone Orientation
3.4.4.1.2 Embedded Vision-Based Solutions
3.4.4.1.3 Digital Technologies
3.5 Penetration And Growth Prospect Mapping For Point Of Care Products, 2021
3.6 Swot By Pest Analysis
3.6.1 Political Landscape
3.6.2 Economic Landscape
3.6.3 Social Landscape
3.6.4 Technology Landscape
3.7 Industry Analysis – Porter’s
3.7.1 Bargaining Power Of Suppliers: Moderate
3.7.2 Bargaining Power Of Buyers: Moderate
3.7.3 Threat Of Substitution: Low
3.7.4 Threat Of New Entrants: Low
3.7.5 Competitive Rivalry: High
3.8 Major Deals & Strategic Alliances Analysis
3.8.1 Joint Ventures
3.8.2 Mergers & Acquisitions
3.8.3 Licensing & Partnership
3.9 Market Entry Strategies
3.10 Price-Cost-Margin Analysis For Point-Of-Care Testing
3.11 User Perspective Analysis
3.11.1 Consumer Behavior Analysis
3.12 Technology Overview
3.13 Poc Diagnostics: Market Influencers
3.13.1 High Sensitivity
3.13.2 Shift To Molecular Diagnostics
3.14 Product Positioning Analysis, 2021
3.14.1 Glucose Testing
3.14.2 Hb1ac Testing
3.14.3 Coagulation Testing
3.14.4 Fertility/Pregnancy
3.14.5 Infectious Disease
3.14.6 Cardiac Markers
3.14.7 Thyroid Stimulating Hormone
3.14.8 Haematology
3.14.9 Primary Care Systems
3.14.10 Decentralized Clinical Chemistry
3.14.11 Feces
3.14.12 Lipid Testing
3.14.13 Cancer Marker
3.14.14 Blood Gas/Electrolytes
3.14.15 Ambulatory Chemistry
3.14.16 Drug Of Abuse (Doa) Testing
3.14.17 Urinalysis/Nephrology
3.15 Regulatory Framework Analysis For U.S. Point Of Care Diagnostics
3.16 Regulatory Framework Analysis For Europe Point Of Care Diagnostics
3.17 Regulatory Framework Analysis For Japan Point Of Care Diagnostics
CHAPTER 4 COVID-19 IMPACT ANALYSIS
4.1 Overview
4.1.1 Covid-19 Point-Of-Care Diagnostics: Technology Overview
4.1.2 Covid-19 Point-Of-Care Diagnostics: Regulatory Overview
CHAPTER 5 COMPETITIVE ANALYSIS.
5.1 Recent Developments & Impact Analysis, By Key Market Participants
5.2 Company/Competition Categorization
5.3 Vendor Landscape
5.3.1 Key Distributors Marketing Channels
5.3.1.1 Abbott Diagnostics
5.3.1.1.1 Abbott Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.1.2 Alere Inc.
5.3.1.1.2.1 Alere: Marketing Channels & Distribution Network For Poc
5.3.1.2 Roche Diagnostics
5.3.1.2.1 Roche Diagnostics: Marketing Channels & Distribution Network For Poc
5.3.1.3 Siemens Healthcare
5.3.1.3.1 Siemens Healthcare: Marketing Channels & Distribution Network For Poc
5.3.1.4 Danaher Corporation
5.3.1.4.1 Danaher Corporation: Marketing Channels & Distribution Network For Poc
5.3.1.5 Instrumentation Laboratory Spa.
5.3.1.5.1 Instrumentation Laboratory Spa.: Marketing Channels & Distribution Network For Poc
5.3.1.6 Becton Dickinson
5.3.1.6.1 Becton Dickinson.: Marketing Channels & Distribution Network For Poc
5.3.2 Key Customers
5.4 Key Company Market Ranking, 2021
5.4.1 Company Size
5.4.2 Distribution Network
5.4.3 Product Portfolio
5.4.4 Segment Coverage
5.4.5 Geographic Presence
5.4.6 Collaborations
5.4.7 Conclusion
5.5 Public Companies
5.5.1 Number Of Products
5.5.2 Market Penetration
5.5.3 Strategic Initiatives
5.5.4 Segment Coverage
5.5.5 Geographical Presence
5.5.6 Competitive Dashboard Analysis
5.6 Market Differentiators
5.6.1 Application Trends
5.6.2 Technology Trends
5.6.3 Test Location Trends
5.6.4 End-Use Trends
5.6.5 Regional Trends
5.7 Private Companies
5.7.1 New Entrants/Emerging Players
5.8 Regional Mapping: Public And Private Companies
CHAPTER 6 PRODUCT BUSINESS ANALYSIS
6.1 Point-Of-Care (Poc) Diagnostics Market: Product Movement Analysis
6.1.1 Glucose Testing
6.1.1.1 Glucose Testingpoint-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.2 Hb1ac Testing
6.1.2.1 Hb1ac Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.3 Coagulation Testing
6.1.3.1 Coagulation Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.4 Fertility/Pregnancy
6.1.4.1 Fertility/Pregnancy Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5 Infectious Diseases
6.1.5.1 Infectious Disease Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.2 Hiv Poc
6.1.5.2.1 Hiv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.3 Clostridium Difficile Poc
6.1.5.3.1 Clostridium Difficile Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.4 Hbv Poc
6.1.5.4.1 Hbv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.5 Pneumonia Or Streptococcus Associated Infections
6.1.5.5.1 Pneumonia Or Streptococcus Associated Infections Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.6 Respiratory Syncytial Virus (Rsv) Poc
6.1.5.6.1 Respiratory Syncytial Virus (Rsv) Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.7 Hpv Poc
6.1.5.7.1 Hpv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.8 Influenza/Flu Poc
6.1.5.8.1 Influenza/Flu Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.9 Hcv Poc
6.1.5.9.1 Hcv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.10 Mrsa Poc
6.1.5.10.1 Mrsa Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.11 Tb And Drug-Resistant Tb Poc
6.1.5.11.1 Tb And Drug-Resistant Tb Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.12 Hsv Poc
6.1.5.12.1 Hsv Poc Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.5.13 Covid-19
6.1.5.13.1 Covid-19 Diagnostics Market Estimates And Forecast, 2020 – 2030 (Usd Million)
6.1.5.14 Other Infectious Diseases
6.1.5.14.1 Other Infectious Disease Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.6 Cardiac Markers
6.1.6.1 Cardiac Markers Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.7 Thyroid Stimulating Hormone
6.1.7.1 Thyroid Stimulating Hormone Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.8 Hematology
6.1.8.1 Hematology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.9 Primary Care Systems
6.1.9.1 Primary Care Systems Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.10 Decentralized Clinical Chemistry
6.1.10.1 Decentralized Clinical Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.11 Feces
6.1.11.1 Feces Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.12 Lipid Testing
6.1.12.1 Lipid Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.13 Cancer Marker
6.1.13.1 Cancer Marker Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.14 Blood Gas/Electrolytes
6.1.14.1 Blood Gas/Electrolytes Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.15 Ambulatory Chemistry
6.1.15.1 Ambulatory Chemistry Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.16 Drug Of Abuse (Doa) Testing
6.1.16.1 Drug Of Abuse (Doa) Testing Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.1.17 Urinalysis/Nephrology
6.1.17.1 Urinalysis/Nephrology Point-Of-Care (Poc) Diagnostics Market Estimates And Forecast, 2018 - 2030 (Usd Million)
CHAPTER 7 END-USE BUSINESS ANALYSIS
7.1 Point-Of-Care (Poc) Diagnostics Market: End-Use Movement Analysis
7.1.1 Clinics
7.1.1.1 Point-Of-Care (Poc) Diagnostics Market For Clinics, 2018 - 2030 (Usd Million)
7.1.1.2 Pharmacy & Retail Clinics
7.1.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Pharmacy & Retail Clinics, 2018 - 2030 (Usd Million)
7.1.1.3 Physician Office
7.1.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Physician Office, 2018 - 2030 (Usd Million)
7.1.1.4 Urgent Care Clinics
7.1.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Urgent Care Clinics, 2018 - 2030 (Usd Million)
7.1.1.5 Non-Practice Clinics
7.1.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Non-Practice Clinics, 2018 - 2030 (Usd Million)
7.1.2 Hospitals
7.1.2.1 Point-Of-Care (Poc) Diagnostics Market For Hospitals, 2018 - 2030 (Usd Million)
7.1.3 Home
7.1.3.1 Point-Of-Care (Poc) Diagnostics Market For Home, 2018 - 2030 (Usd Million)
7.1.4 Assisted Living Healthcare Facilities
7.1.4.1 Point-Of-Care (Poc) Diagnostics Market For Assisted Living Healthcare Facilities, 2018 - 2030 (Usd Million)
7.1.5 Laboratory
7.1.5.1 Point-Of-Care (Poc) Diagnostics Market For Laboratory, 2018 - 2030 (Usd Million)
CHAPTER 8 REGION BUSINESS ANALYSIS
8.1 Point-Of-Care (Poc) Diagnostics Market: Regional Movement Analysis, 2021 & 2030
8.2 North America
8.2.1.1 North America Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.2.2 U.S.
8.2.3 Canada
8.3 Europe
8.3.1.1 Europe Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Italy
8.3.6 Spain
8.3.7 Russia
8.4 Asia Pacific
8.4.1.1 Asia Pacific Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.4.2 Japan
8.4.3 China
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.5 Latin America
8.5.1.1 Latin America Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.5.2 Brazil
8.5.3 Mexico
8.6 Middle East & Africa (Mea)
8.6.1.1 Middle East & Africa Point-Of-Care (Poc) Diagnostics Market, 2018 - 2030 (Usd Million)
8.6.2 South Africa
8.6.3 Saudi Arabia
CHAPTER 9 COMPANY PROFILE
9.1 Company Profiles
9.1.1 Wipro Limited
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 Zoe Global Limited
9.1.2.1 Company Overview
9.1.2.2 Product Benchmarking
9.1.3 Vocalis Health
9.1.3.1 Company Overview
9.1.3.2 Product Benchmarking
9.1.3.3 Strategic Initiatives
9.1.4 Darwinai
9.1.4.1 Company Overview
9.1.4.2 Product Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Biocogniv, Inc.
9.1.5.1 Company Overview
9.1.5.2 Product Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 Laipac Technology, Inc.
9.1.6.1 Company Overview
9.1.6.2 Product Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Gauss Surgical
9.1.7.1 Company Overview
9.1.7.2 Product Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Oxford Immune Algorithmics Ltd.
9.1.8.1 Company Overview
9.1.8.2 Product Benchmarking
9.1.8.3 Strategic Initiatives
9.1.9 F. Hoffmann-La Roche Ltd.
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Qiagen
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11 Danaher Corporation
9.1.11.1 Company Overview
9.1.11.2 Beckman Coulter, Inc.
9.1.11.2.1 Company Overview
9.1.11.2.2 Radiometer Medical Aps
9.1.11.2.3 Hemocue Ab
9.1.11.3 Financial Performance
9.1.11.4 Product Benchmarking
9.1.11.5 Strategic Initiatives
9.1.12 Becton Dickinson (Bd)
9.1.12.1 Company Overview
9.1.12.2 Financial Performance
9.1.12.3 Product Benchmarking
9.1.12.4 Strategic Initiatives
9.1.13 Biomerieux Sa
9.1.13.1 Company Overview
9.1.13.2 Financial Performance
9.1.13.3 Product Benchmarking
9.1.13.4 Strategic Initiatives
9.1.14 Abbott
9.1.14.1 Company Overview
9.1.14.2 Alere, Inc.
9.1.14.2.1 Company Overview
9.1.14.3 Financial Performance
9.1.14.4 Product Benchmarking
9.1.14.5 Strategic Initiatives
9.1.14.5.1 Strategic Initiatives (Alere)
9.1.15 Siemens Healthcare Ag
9.1.15.1 Company Overview
9.1.15.2 Financial Performance
9.1.15.3 Product Benchmarking
9.1.15.4 Strategic Initiatives
9.1.16 Zoetis, Inc.
9.1.16.1 Company Overview
9.1.16.2 Abaxis
9.1.16.3 Company Overview
9.1.16.4 Financial Performance
9.1.16.4.1 Financial Performance (Abaxis)
9.1.16.5 Product Benchmarking
9.1.16.6 Strategic Initiatives
9.1.17 Instrumentation Laboratory
9.1.17.1 Company Overview
9.1.17.2 Accriva Diagnostics
9.1.17.2.1 Company Overview
9.1.17.3 International Technidyne Corporation (Itc)
9.1.17.3.1 Company Overview
9.1.17.4 Financial Performance (Instrumentation Laboratory)
9.1.17.4.1 Financial Performance (International Technidyne)
9.1.17.5 Product Benchmarking
9.1.17.6 Strategic Initiatives
9.1.18 Nova Biomedical
9.1.18.1 Company Overview
9.1.18.2 Financial Performance
9.1.18.3 Product Benchmarking
9.1.18.4 Strategic Initiatives
9.1.19 Trividia Health, Inc.
9.1.19.1 Company Overview
9.1.19.2 Financial Performance
9.1.19.3 Product Benchmarking
9.1.19.4 Strategic Initiatives
9.1.20 Quidel Corporation
9.1.20.1 Company Overview
9.1.20.2 Financial Performance
9.1.20.3 Product Benchmarking
9.1.20.4 Strategic Initiatives
9.1.21 Trinity Biotech
9.1.21.1 Company Overview
9.1.21.2 Financial Performance
9.1.21.3 Product Benchmarking
9.1.21.4 Strategic Initiatives
9.1.22 Sekisui Diagnostics
9.1.22.1 Company Overview
9.1.22.2 Product Benchmarking
9.1.22.3 Strategic Initiatives
9.1.23 Orasure Technologies, Inc.
9.1.23.1 Company Overview
9.1.23.2 Financial Performance
9.1.23.3 Product Benchmarking
9.1.23.4 Strategic Initiatives
9.1.24 Nipro
9.1.24.1 Company Overview
9.1.24.2 Financial Performance
9.1.24.3 Product Benchmarking
9.1.25 Spectral Medical Inc.
9.1.25.1 Company Overview
9.1.25.2 Financial Performance
9.1.25.3 Product Benchmarking
LIST OF TABLES
Table 1 List of secondary sources
Table 2 Examples: CLIA waived tests
Table 3 North America diabetes prevalence (national prevalence %), 2013 & 2035
Table 4 Europe diabetes prevalence (national prevalence %), 2013 & 2035
Table 5 Asia Pacific diabetes prevalence (national prevalence %), 2013 & 2035
Table 6 Latin America Diabetes Prevalence (national prevalence %), 2013 & 2035
Table 7 MEA and Africa diabetes prevalence (national prevalence %), 2013 & 2035
Table 8 CIS diabetes prevalence (national prevalence %), 2013 & 2035
Table 9 Description of POC devices for detection of diseases through specific salivary biomarkers
Table 10 Methods used for the evaluation of diagnostic toolboxes
Table 11 List of companies operating in the COVID-19 Point of Care diagnostics market
Table 12 Abbott Healthcare: List of Wholesalers & Distributors
Table 13 North America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 14 North America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 16 U.S. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 18 Canada point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 20 Europe point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 22 Germany point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 23 U.K. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 24 U.K. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 25 National and international requirements for quality management of Point of Care testing in France
Table 26 France point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 27 France point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 29 Italy point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 30 Spain point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 31 Spain point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 32 Russia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 33 Russia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 36 Japan point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 37 Japan point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 38 China point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 39 China point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 40 Some of the local glucose POC testing manufacturers in india
Table 41 India point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 42 India point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 43 Primary guidelines for glucose POC testing in Australia
Table 44 Australia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 45 Australia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 46 South Korea point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 47.South Korea point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 48 Latin America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 49 Latin America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 50 Brazil point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 51 Brazil point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 52 Mexico point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 53 Mexico point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 56 South Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 57 South Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 Examples: CLIA waived tests
Table 3 North America diabetes prevalence (national prevalence %), 2013 & 2035
Table 4 Europe diabetes prevalence (national prevalence %), 2013 & 2035
Table 5 Asia Pacific diabetes prevalence (national prevalence %), 2013 & 2035
Table 6 Latin America Diabetes Prevalence (national prevalence %), 2013 & 2035
Table 7 MEA and Africa diabetes prevalence (national prevalence %), 2013 & 2035
Table 8 CIS diabetes prevalence (national prevalence %), 2013 & 2035
Table 9 Description of POC devices for detection of diseases through specific salivary biomarkers
Table 10 Methods used for the evaluation of diagnostic toolboxes
Table 11 List of companies operating in the COVID-19 Point of Care diagnostics market
Table 12 Abbott Healthcare: List of Wholesalers & Distributors
Table 13 North America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 14 North America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 16 U.S. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 18 Canada point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 20 Europe point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 22 Germany point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 23 U.K. point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 24 U.K. point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 25 National and international requirements for quality management of Point of Care testing in France
Table 26 France point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 27 France point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 29 Italy point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 30 Spain point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 31 Spain point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 32 Russia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 33 Russia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 36 Japan point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 37 Japan point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 38 China point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 39 China point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 40 Some of the local glucose POC testing manufacturers in india
Table 41 India point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 42 India point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 43 Primary guidelines for glucose POC testing in Australia
Table 44 Australia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 45 Australia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 46 South Korea point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 47.South Korea point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 48 Latin America point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 49 Latin America point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 50 Brazil point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 51 Brazil point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 52 Mexico point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 53 Mexico point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 56 South Africa point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 57 South Africa point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia point of care (PoC) diagnostics market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market revenue model
Fig. 5 POC segment penetration mapping
Fig. 6 Pricing analysis
Fig. 7 Market research approaches
Fig. 8 Value chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Market summary, 2021 (USD Million)
Fig. 12 Market trends & outlook
Fig. 13 Market segmentation & scope
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Point of care diagnostics market: Driver relevance analysis (Current & future impact)
Fig. 17 Shift in POC molecular diagnostic trends
Fig. 18 Global percentage of population, by age group, 2000 and 2050
Fig. 19 Population over the age of 65 years, by region, 2010 and 2050
Fig. 20 Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
Fig. 21 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
Fig. 22 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
Fig. 23 Point of care diagnostics market: Challenge relevance analysis (Current & future impact)
Fig. 24 Point of care diagnostics market: Opportunity relevance analysis (Current & future impact)
Fig. 25 Accountable factors to ensure adequate accessibility of POC diagnostic solutions
Fig. 26 Penetration and growth prospect mapping
Fig. 27 Factors impacting market entry strategies
Fig. 28 Key market entry methods
Fig. 29 Consumption trends for POCT
Fig. 30 Product positioning analysis, 2021
Fig. 31 COVID-19 point of care (PoC) diagnostics market: Trend analysis
Fig. 32 COVID-19 Point of Care diagnostics: Technology landscape
Fig. 33 Recent Developments & Impact Analysis, by Key Market Participants
Fig. 34 Key market participants: Impact analysis, 2021
Fig. 35 Key market participants: Revenue-strategy mapping
Fig. 36 Company categorization
Fig. 37 Marketing channels
Fig. 38 Key customers
Fig. 39 Competitive Landscape POC Diagnostics - Major market participants
Fig. 40 Competitive dashboard analysis for public players
Fig. 41 Roche Distribution Presence
Fig. 42 Instrumentation Laboratory (Werfen Group) Distribution Presence
Fig. 43 Abbott Laboratories Distribution Network Coverage
Fig. 44 Alere Distribution Presence
Fig. 45 Siemens Healthcare Distribution Presence
Fig. 46 Danaher Distribution Presence (Radiometer, HemoCue, and Beckman Coulter)
Fig. 47 Becton Dickinson Presence
Fig. 48 Point of care (PoC) diagnostics market: Product outlook and key takeaways
Fig. 49 Point of care (PoC) diagnostics market: Product movement analysis
Fig. 50 Glucose testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Hb1Ac testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Coagulation testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Fertility/pregnancy point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Infectious disease point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 HIV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Clostridium Difficile POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 HBV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Pneumonia or streptococcus associated infections point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Respiratory syncytial virus (RSV) POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 HPV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 influenza/Flu POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 HCV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 MRSA POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 TB and drug-resistant TB POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 HSV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 67 Other infectious disease diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Cardiac markers point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thyroid stimulating hormone point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Hematology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Primary care systems point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Decentralized clinical chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Feces point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Lipid testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Cancer marker point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Blood gas/electrolytes point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Ambulatory chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Drug of abuse (DOA) testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Urinalysis/nephrology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Point of Care (PoC) diagnostics market: End-use outlook and key takeaways
Fig. 81 Point of Care (PoC) diagnostics market: End-use movement analysis
Fig. 82 Point of Care (PoC) diagnostics market for clinics, 2018 - 2030 (USD Million)
Fig. 83 Point of Care (PoC) diagnostics market for pharmacy & retail clinics, 2018 - 2030 (USD Million)
Fig. 84 Point of Care (PoC) diagnostics market for physician office, 2018 - 2030 (USD Million)
Fig. 85 Point of Care (PoC) diagnostics market for urgent care clinics, 2018 - 2030 (USD Million)
Fig. 86 Point of Care (PoC) diagnostics market for non-practice clinics, 2018 - 2030 (USD Million)
Fig. 87 Point of Care (PoC) diagnostics market for hospitals, 2018 - 2030 (USD Million)
Fig. 88 Point of Care (PoC) diagnostics market for home, 2018 - 2030 (USD Million)
Fig. 89 Point of Care (PoC) diagnostics market for assisted living healthcare facilities, 2018 - 2030 (USD Million)
Fig. 90 Point of Care (PoC) diagnostics market for laboratory, 2018 - 2030 (USD Million)
Fig. 91 Regional market place: Key takeaway
Fig. 92 POC diagnostics market: Region movement analysis
Fig. 93 North America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 94 U.S. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 95 Canada point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 96 Europe point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 97 Germany point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 98 U.K. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 99 France point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 100 Italy point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 101 Spain point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 102 Russia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 103 Asia Pacific point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 104 Japan point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 105 China point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 106 India point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 107 Australia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 108 South Korea point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 109 Latin America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 110 Brazil point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 111 Mexico point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 112 Middle East & Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 113 South Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 114 Saudi Arabia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market revenue model
Fig. 5 POC segment penetration mapping
Fig. 6 Pricing analysis
Fig. 7 Market research approaches
Fig. 8 Value chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Market summary, 2021 (USD Million)
Fig. 12 Market trends & outlook
Fig. 13 Market segmentation & scope
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Point of care diagnostics market: Driver relevance analysis (Current & future impact)
Fig. 17 Shift in POC molecular diagnostic trends
Fig. 18 Global percentage of population, by age group, 2000 and 2050
Fig. 19 Population over the age of 65 years, by region, 2010 and 2050
Fig. 20 Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
Fig. 21 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
Fig. 22 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
Fig. 23 Point of care diagnostics market: Challenge relevance analysis (Current & future impact)
Fig. 24 Point of care diagnostics market: Opportunity relevance analysis (Current & future impact)
Fig. 25 Accountable factors to ensure adequate accessibility of POC diagnostic solutions
Fig. 26 Penetration and growth prospect mapping
Fig. 27 Factors impacting market entry strategies
Fig. 28 Key market entry methods
Fig. 29 Consumption trends for POCT
Fig. 30 Product positioning analysis, 2021
Fig. 31 COVID-19 point of care (PoC) diagnostics market: Trend analysis
Fig. 32 COVID-19 Point of Care diagnostics: Technology landscape
Fig. 33 Recent Developments & Impact Analysis, by Key Market Participants
Fig. 34 Key market participants: Impact analysis, 2021
Fig. 35 Key market participants: Revenue-strategy mapping
Fig. 36 Company categorization
Fig. 37 Marketing channels
Fig. 38 Key customers
Fig. 39 Competitive Landscape POC Diagnostics - Major market participants
Fig. 40 Competitive dashboard analysis for public players
Fig. 41 Roche Distribution Presence
Fig. 42 Instrumentation Laboratory (Werfen Group) Distribution Presence
Fig. 43 Abbott Laboratories Distribution Network Coverage
Fig. 44 Alere Distribution Presence
Fig. 45 Siemens Healthcare Distribution Presence
Fig. 46 Danaher Distribution Presence (Radiometer, HemoCue, and Beckman Coulter)
Fig. 47 Becton Dickinson Presence
Fig. 48 Point of care (PoC) diagnostics market: Product outlook and key takeaways
Fig. 49 Point of care (PoC) diagnostics market: Product movement analysis
Fig. 50 Glucose testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Hb1Ac testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Coagulation testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Fertility/pregnancy point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Infectious disease point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 HIV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Clostridium Difficile POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 HBV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Pneumonia or streptococcus associated infections point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Respiratory syncytial virus (RSV) POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 HPV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 influenza/Flu POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 HCV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 MRSA POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 TB and drug-resistant TB POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 HSV POC diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 COVID-19 diagnostics market, 2020 - 2030 (USD Million)
Fig. 67 Other infectious disease diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Cardiac markers point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thyroid stimulating hormone point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Hematology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Primary care systems point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Decentralized clinical chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Feces point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Lipid testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Cancer marker point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Blood gas/electrolytes point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Ambulatory chemistry point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Drug of abuse (DOA) testing point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Urinalysis/nephrology point of care (PoC) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Point of Care (PoC) diagnostics market: End-use outlook and key takeaways
Fig. 81 Point of Care (PoC) diagnostics market: End-use movement analysis
Fig. 82 Point of Care (PoC) diagnostics market for clinics, 2018 - 2030 (USD Million)
Fig. 83 Point of Care (PoC) diagnostics market for pharmacy & retail clinics, 2018 - 2030 (USD Million)
Fig. 84 Point of Care (PoC) diagnostics market for physician office, 2018 - 2030 (USD Million)
Fig. 85 Point of Care (PoC) diagnostics market for urgent care clinics, 2018 - 2030 (USD Million)
Fig. 86 Point of Care (PoC) diagnostics market for non-practice clinics, 2018 - 2030 (USD Million)
Fig. 87 Point of Care (PoC) diagnostics market for hospitals, 2018 - 2030 (USD Million)
Fig. 88 Point of Care (PoC) diagnostics market for home, 2018 - 2030 (USD Million)
Fig. 89 Point of Care (PoC) diagnostics market for assisted living healthcare facilities, 2018 - 2030 (USD Million)
Fig. 90 Point of Care (PoC) diagnostics market for laboratory, 2018 - 2030 (USD Million)
Fig. 91 Regional market place: Key takeaway
Fig. 92 POC diagnostics market: Region movement analysis
Fig. 93 North America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 94 U.S. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 95 Canada point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 96 Europe point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 97 Germany point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 98 U.K. point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 99 France point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 100 Italy point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 101 Spain point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 102 Russia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 103 Asia Pacific point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 104 Japan point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 105 China point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 106 India point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 107 Australia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 108 South Korea point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 109 Latin America point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 110 Brazil point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 111 Mexico point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 112 Middle East & Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 113 South Africa point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
Fig. 114 Saudi Arabia point of care (PoC) diagnostics market, 2018 - 2030 (USD Million)
